The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit Sabrina L. Spencer1, Steven D. Cappell1, Feng-Chiao Tsai1, Tobias Meyer1 Tissue homeostasis in metazoans is regulated

First Page		Document Content
Date: 2013-07-16 19:10:08 Restriction point P21 Cyclin Cell growth G1 phase Mitogen CDK inhibitor Mitotic exit NUMB Biology Cell biology Cell cycle		The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit Sabrina L. Spencer1, Steven D. Cappell1, Feng-Chiao Tsai1, Tobias Meyer1 Tissue homeostasis in metazoans is regulated Add to Reading List Source URL: q-bio.org Download Document from Source Website File Size: 23,11 KB Share Document on Facebook

	Microsoft PowerPoint - Figure 1 Final 1.ppt DocID: 1a9KF - View Document
	Preliminary Programme Cell Cycle Regulators/Inhibitors and Cancer February 5-8, 2011, Vienna Austria Saturday, February – 18.00 DocID: 17yuA - View Document
	DOI:.CANChromosomal Instability Confers Intrinsic Multidrug Resistance Alvin J.X. Lee, David Endesfelder, Andrew J. Rowan, et al. Cancer Res 2011;71:Published online March 1, 2011. DocID: 15Vm4 - View Document
	The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit Sabrina L. Spencer1, Steven D. Cappell1, Feng-Chiao Tsai1, Tobias Meyer1 Tissue homeostasis in metazoans is regulated DocID: 13yxU - View Document
	Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase DocID: 13cEL - View Document